
|Articles|August 1, 2004
Supplements and Featured Publications
- Newsletter - Inflammation, Metabolic Syndrome, and CV Risk Reduction
- Volume 10
- Issue 2 Metab
CE / CME
Advertisement
Articles in this issue
over 21 years ago
Commentaryover 21 years ago
Post Testover 21 years ago
Faculty Disclosure Statementover 21 years ago
Metabolic syndrome: A new target of therapy?Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
ACIP Delayed Hepatitis B Vaccine Schedule Vote Amid Safety Controversy
2
Most Americans Pleased With Health Insurance Options for 2026
3
Medicaid Expansion Associated With Lower Mortality in NSCLC
4
Hereditary Ovarian Cancer Genes Found Beyond Traditionally High-Risk Groups
5












































